9,10-dimethyl-1,2-benzanthracene has been researched along with fluorouracil in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, HL; Bradley-Moore, PR; Casella, V; Fowler, JS; Greenberg, D; Ido, T; Lambrecht, RM; MacGregor, R; Mantescu, C; Meaney, K; Neirinckx, R; Schlesinger, T; Shani, J; Som, P; Wodinsky, I; Wolf, AP; Wolf, W | 1 |
| Fiebig, HH; Schmähl, D | 3 |
| Horiuchi, R; Iino, Y; Ishikita, T; Maemura, M; Morishita, Y; Ohwada, S; Sugamata, N; Yokoe, T; Yoshida, M | 1 |
| Croisy, A; Guerquin-Kern, JL; Leteurtre, F; Lhoste, JM | 1 |
| Komaki, K; Konishi, N; Monden, Y; Mori, T; Morimoto, T; Sasa, M; Tanaka, T; Yamakawa, T; Yamamoto, H | 1 |
| Monden, A; Morimoto, T; Yamamoto, H | 1 |
| Ohsaka, F | 1 |
| Harada, H | 1 |
| Arai, T; Endo, K; Hoshino, K; Iino, Y; Ishida, T; Ishikawa, H; Ogawa, T; Takahashi, T; Yamazaki, K; Yokoe, T | 1 |
| Bowie, M; Budinger, JM; Chou, TC; Stock, CC; Teller, MN | 1 |
| Kennedy, BJ; Kiang, DT | 1 |
| Higashikuni, N; Sutou, S | 1 |
| Coulter, K; Morris, RJ; Steinberg, SR; Tryson, K | 1 |
| Iversen, VV; Maehle, BO; Reed, RK; Straume, O; Stuhr, LE | 1 |
| Iversen, VV; Reed, RK; Rubin, K; Salnikov, AV; Salvesen, G; Stuhr, LE | 1 |
| Hayward, R; Lo, RS; Marais, R; Martin, M; Niculescu-Duvaz, D; Sanchez-Laorden, B; Springer, C; Viros, A; Yashar, S; Yu, CC; Zambon, A | 1 |
| Ahn, JS; Cha-Molstad, H; Choi, TW; Han, HJ; Hong, JT; Hwang, J; Kim, BY; Kim, HJ; Kwon, YT; Lee, HG; Lee, KH; Lee, Y; Mun, J; Soung, NK | 1 |
| Agrawal, RK; Iyer, AK; Jain, S; Kashaw, SK; Kushwah, V; Sahu, P; Sau, S | 1 |
1 review(s) available for 9,10-dimethyl-1,2-benzanthracene and fluorouracil
| Article | Year |
|---|---|
Endocrine and cytostatic treatment of experimental mammary cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carmustine; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Ergolines; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methotrexate; Methylnitrosourea; Mice; Nitrosourea Compounds; Prednisolone; Rats; Tamoxifen; Vincristine | 1980 |
1 trial(s) available for 9,10-dimethyl-1,2-benzanthracene and fluorouracil
| Article | Year |
|---|---|
Chemoendocrine therapy in advanced breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Female; Fluorouracil; Humans; Mammary Neoplasms, Experimental; Menopause; Neoplasms, Hormone-Dependent; Random Allocation; Rats; Rats, Inbred Strains; Receptors, Estrogen | 1981 |
18 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and fluorouracil
| Article | Year |
|---|---|
Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Fluorine; Fluorouracil; Leukemia, Experimental; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Radioisotopes; Rats; Rats, Inbred BUF; Rats, Inbred F344; Sarcoma, Experimental; Tissue Distribution | 1978 |
[Synergistic therapeutic effect of adriamycin with 5-fluor-uracil, with prednisolon and with cyclophosphamide on chemically induced mammary cancer of the rat (author's transl)].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methotrexate; Prednisolone; Rats; Vincristine | 1977 |
The effect of ovariectomy, tamoxifen and the combination adriamycin and 5-FU on 7,12-dimethylbenz(a)anthracene induced mammary cancer of the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Castration; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Mammary Neoplasms, Experimental; Rats; Remission, Spontaneous; Stilbenes; Tamoxifen | 1977 |
1 alpha-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Female; Fluorouracil; Hydroxycholecalciferols; Hypercalcemia; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Rats; Rats, Sprague-Dawley; Weight Loss | 1992 |
pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; beta-Alanine; Fibrosarcoma; Fluorine; Fluorouracil; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Phosphorus; Rats; Rats, Inbred Strains; Urea | 1991 |
Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
[Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
[Pyrimidine nucleotide biosynthesis and 5-fluorouracil metabolism in DMBA-induced tongue carcinoma].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cricetinae; Fluorouracil; Male; Mesocricetus; Pyrimidine Nucleotides; Tongue Neoplasms | 1986 |
[Experimental studies on rat ear duct tumor. Part 2: Effects of anticancer drugs on rat ear duct tumor induced by DMBA and DAS (author's transl)].
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 9,10-Dimethyl-1,2-benzanthracene; Animals; Bleomycin; Carcinoma, Squamous Cell; Ear Neoplasms; Fluorouracil; Neoplasms, Experimental; Rats | 1980 |
[Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Rats; Receptors, Estrogen; Receptors, Progesterone | 1984 |
Therapy of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas with combinations of 5-fluorouracil and 2 alpha-methyldihydrotestosterone propionate.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstanols; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluorouracil; Mammary Neoplasms, Experimental; Mice | 1982 |
An optimal, generalized sampling time of 30 +/- 6 h after double dosing in the mouse peripheral blood micronucleus test.
Topics: 2-Acetylaminofluorene; 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carcinogens; Colchicine; Cyclophosphamide; Cytarabine; Floxuridine; Fluorouracil; Kinetics; Methotrexate; Mice; Mice, Inbred Strains; Micronucleus Tests; Mitomycin; Mutagens; Reticulocytes; Sulfuric Acid Esters; Time Factors | 1995 |
Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Antimetabolites, Antineoplastic; Carcinogens; Cell Division; Epidermis; Female; Fluorouracil; Hair Follicle; Mice; Neoplasms, Experimental; Papilloma; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1997 |
Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Cell Division; Drug Combinations; Female; Fluorouracil; Hyperbaric Oxygenation; Mammary Neoplasms, Experimental; Microcirculation; Oxygen; Rats; Rats, Sprague-Dawley | 2004 |
High-dose, short-term, anti-inflammatory treatment with dexamethasone reduces growth and augments the effects of 5-fluorouracil on dimethyl-alpha-benzanthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Carcinogens; Dexamethasone; Drug Administration Schedule; Drug Synergism; Extracellular Fluid; Female; Fluorouracil; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Pressure; Rats; Rats, Sprague-Dawley | 2006 |
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Cell Line; Cell Proliferation; Fluorouracil; Humans; Imidazoles; Indoles; Melanoma; Mice; Oximes; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Tetradecanoylphorbol Acetate; Vemurafenib | 2013 |
A novel tubulin inhibitor STK899704 induces tumor regression in DMBA/TPA-induced skin carcinogenesis model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Benzofurans; Carcinogenesis; Colchicine; Disease Models, Animal; Fluorouracil; Male; Mice; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tubulin; Tubulin Modulators | 2018 |
pH Responsive 5-Fluorouracil Loaded Biocompatible Nanogels For Topical Chemotherapy of Aggressive Melanoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Biocompatible Materials; Cell Line; Cell Proliferation; Cell Survival; Drug Carriers; Fluorouracil; Humans; Hydrogen-Ion Concentration; Male; Melanoma; Mice; Nanogels; Neoplasms, Experimental; Particle Size; Polyethylene Glycols; Polyethyleneimine; Surface Properties | 2019 |